Trial Profile
Randomized, Double-blind, Parallel-group, Phase 1 Study.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Sep 2020
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Ankylosing spondylitis
- Focus Pharmacokinetics; Registrational
- Acronyms PLANETAS
- Sponsors Celltrion
- 09 Sep 2020 Results of two trials ( PLANETRA and PLANETAS)published in the Journal of Clinical Pharmacology
- 13 Jun 2015 Results of retrospective analysis of pooled data from PLANETAS and PLANETRA trials presented at the 16th Annual Congress of the European League Against Rheumatism.
- 30 Oct 2013 Efficacy results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.